Chlordiazepoxide hydrochloride
Chlordiazepoxide Hydrochloride, also known as Librium, is a prescription benzodiazepine medication used to treat anxiety disorders and symptoms of alcohol withdrawal. It comes in 5 mg oral capsules manufactured by Epic Pharma, LLC, and is classified as a Schedule IV controlled substance. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Chlordiazepoxide Hydrochloride, also known as Librium, is a prescription benzodiazepine medication used to treat anxiety disorders and symptoms of alcohol withdrawal. It comes in 5 mg oral capsules manufactured by Epic Pharma, LLC, and is classified as a Schedule IV controlled substance. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Chlordiazepoxide hydrochloride", "mediaType": "text/html", "description": " Access the FDA dataset for Chlordiazepoxide hydrochloride — ANDA 085461 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=085461" } ] |
| identifier | ANDA085461 |
| issued | 2016-09-16 |
| keyword |
[ "drug-information", "health-care", "pharmaceuticals", "prescription-drugs", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Chlordiazepoxide hydrochloride |
